ROS implication in a new antitumor strategy based on non-thermal plasma

Marc Vandamme1, Eric Robert, Stéphanie Lerondel

  • 1GERMITEC SAS, 30 rue Mozart, 92110 CLICHY, France. marc.vandamme@cnrs-orleans.fr

Summary

Non-thermal plasma (NTP) effectively treats cancer by generating reactive oxygen species (ROS) to induce cancer cell death. This study shows NTP reduces tumor volume and arrests cancer cell proliferation in vitro and in vivo.